BioProcess International European Summit

Cell Line Development

We at Novo Nordisk Pharmatech A/S are pleased to announce that we will be a part of the annual BioProcess International European Summit held in Amsterdam on April 23-25, and Novo Nordisk Pharmatech A/S will be present at booth #108.

We hereby invite you to visit our booth and discover more about recombinant insulin for innovative biologics and pharmaceutical grade Quaternary ammonium compounds.

At Novo Nordisk Pharmatech we remain the  leading worldwide supplier of recombinant insulin. Our recombinant insulin is a key component in serum free growth media for mammalian cells and approved by regulatory bodies worldwide, including FDA and EMA, and our products are manufactured to cGMP standards, and we guarantee:

  • Global regulatory compliance
  • Consistent high quality
  • Extensive regulatory documentation
  • Continuous availability
  • Secure global supply chain
  • High levels of service and support

We deliver a proven record of product PurityReliability and Consistency and can even tailor Quality products for future therapies

Increase viable CHO cell density in commercial available cell culture medium by supplementation with non-animal insulin

CHO cells are one of the most widely used platforms for the production of biopharmaceuticals. Increased demand for safety and reliability has moved the standard for CHO cell culture media from Serum containing to Serum free and further on to chemically defined media. UAB in collaboration with Novo Nordisk Pharmatech (world’s largest supplier of recombinant insulin) has shown that addition of animal origin free insulin to three leading commercially available off-the-shelf chemically defined media resulted in significant increases in viable cell density. In addition to this benefit insulin has been proven to aid in the expression of difficult to express proteins. Please stop by our booth for a talk how insulin could play an important role in your upstream process and for the chance to win an Amazon kindle.

Read More


If you want to learn more about our recombinant Insulin Human click here

We look forward to see you at our both and offer you a chance to discover more about our recombinant insulin for innovative biologics.


"The 6th Annual Cell Line Development & Engineering Asia provides a platform to facilitate discussion on accelerating cell line products time to market, increasing efficiency, efficacy and improving quality in the cell line development process."



Magnus Franzmann

Sales Manager, Insulin


Direct phone: +45 2429 4105